{"transactions":[{"id":731650,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T21:41:31.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Automatically granted pursuant to the terms of the Company's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on June 17, 2027 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on June 17, 2029. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan)."}],"balance_after":50000,"derivative":{"exercise_price":9.42,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001193125-26-276166","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631338/000119312526276166/ownership.xml","form_type":"4"}},{"id":967047,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-16T21:35:36.000Z","date":"2025-12-12","kind":"exercise","planned":false,"acquired":false,"shares":9333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.14,"expiration_date":"2026-03-09","underlying":"Common Stock","underlying_shares":9333},"source":{"system":"sec-edgar","filing":"0001193125-25-320992","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631338/000119312525320992/ownership.xml","form_type":"4"}},{"id":967046,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-16T21:35:36.000Z","date":"2025-12-12","kind":"exercise","planned":false,"acquired":true,"shares":9333,"price":1.14,"value":10639.62,"ownership":{"direct":true},"balance_after":41684,"source":{"system":"sec-edgar","filing":"0001193125-25-320992","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631338/000119312525320992/ownership.xml","form_type":"4"}},{"id":1104583,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:04:33.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Automatically granted pursuant to the terms of the Company's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on June 17, 2026 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on June 17, 2028. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan)."}],"balance_after":22500,"derivative":{"exercise_price":4.15,"expiration_date":"2035-06-16","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000950170-25-088487","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631338/000095017025088487/ownership.xml","form_type":"4"}},{"id":1470517,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-06-24T16:05:06.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":2200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the number of shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of the grant date, subject to the Reporting Person's continued service through such vesting date."}],"balance_after":2200,"derivative":{"exercise_price":8.1,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":2200},"source":{"system":"sec-edgar","filing":"0000950170-24-076705","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260990/000095017024076705/ownership.xml","form_type":"4"}},{"id":1503224,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right To Buy)","published_at":"2024-05-23T23:16:50.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatically granted pursuant to the terms of the Company's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 21, 2025 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 21, 2027. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan)."}],"balance_after":22500,"derivative":{"exercise_price":25.15,"expiration_date":"2034-05-20","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000950170-24-064220","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631338/000095017024064220/ownership.xml","form_type":"4"}},{"id":1578327,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-03-13T17:56:13.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":518300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to this option shall vest on the first anniversary of the Grant Date shown in column 3 above. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter, on the last day of each month."}],"balance_after":518300,"derivative":{"exercise_price":0.39,"expiration_date":"2034-03-11","underlying":"Common Stock","underlying_shares":518300},"source":{"system":"sec-edgar","filing":"0001415889-24-007846","document":"form4-03132024_090306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000141588924007846/form4-03132024_090306.xml","form_type":"4"}},{"id":1578326,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-13T17:56:13.000Z","date":"2023-10-20","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":0.1333,"value":466.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on October 20, 2023."}],"balance_after":406417,"source":{"system":"sec-edgar","filing":"0001415889-24-007846","document":"form4-03132024_090306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000141588924007846/form4-03132024_090306.xml","form_type":"4"}},{"id":1578325,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-13T17:56:13.000Z","date":"2023-04-20","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":0.1377,"value":481.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on April 20, 2023."}],"balance_after":402917,"source":{"system":"sec-edgar","filing":"0001415889-24-007846","document":"form4-03132024_090306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000141588924007846/form4-03132024_090306.xml","form_type":"4"}},{"id":1840941,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-06-30T16:00:24.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the number of shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of the grant date, subject to the Reporting Person's continued service through such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":0.3553,"expiration_date":"2033-06-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-23-040285","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260990/000120919123040285/doc4.xml","form_type":"4"}},{"id":1877651,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-25T23:35:36.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatically granted pursuant to the terms of the Company's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 23, 2024 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 23, 2026. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan)."}],"balance_after":22500,"derivative":{"exercise_price":17.98,"expiration_date":"2033-05-22","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001610717-23-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631338/000161071723000070/form4.xml","form_type":"4"}},{"id":1911179,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-28T06:00:11.000Z","date":"2023-04-27","kind":"purchase","planned":false,"acquired":true,"shares":47000,"price":0.75,"value":35250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.72 to $0.7596, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":399417,"source":{"system":"sec-edgar","filing":"0001209191-23-025930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919123025930/doc4.xml","form_type":"4"}},{"id":1911178,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-28T06:00:11.000Z","date":"2023-04-26","kind":"purchase","planned":false,"acquired":true,"shares":3999,"price":0.66,"value":2639.34,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,500 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on April 20, 2023."}],"balance_after":352417,"source":{"system":"sec-edgar","filing":"0001209191-23-025930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919123025930/doc4.xml","form_type":"4"}},{"id":1978833,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-02T06:24:47.000Z","date":"2023-03-01","kind":"purchase","acquired":true,"shares":4800,"price":1.52,"value":7296.0,"ownership":{"direct":true},"balance_after":344918,"source":{"system":"sec-edgar","filing":"0001209191-23-014434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919123014434/doc4.xml","form_type":"4"}},{"id":1978832,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-02T06:24:47.000Z","date":"2023-02-28","kind":"purchase","acquired":true,"shares":200,"price":1.52,"value":304.0,"ownership":{"direct":true},"balance_after":340118,"source":{"system":"sec-edgar","filing":"0001209191-23-014434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919123014434/doc4.xml","form_type":"4"}},{"id":2032324,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-02-03T19:55:27.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":332000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to this option shall vest on the first anniversary of the Grant Date shown in column 3 above. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter, on the last day of each month."}],"balance_after":332000,"derivative":{"exercise_price":1.7,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":332000},"source":{"system":"sec-edgar","filing":"0001209191-23-007191","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919123007191/doc4.xml","form_type":"4"}},{"id":2050490,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-19T06:05:09.000Z","date":"2023-01-18","kind":"purchase","acquired":true,"shares":6800,"price":1.62,"value":11016.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6065 to $1.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":339918,"source":{"system":"sec-edgar","filing":"0001209191-23-003934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919123003934/doc4.xml","form_type":"4"}},{"id":2084872,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-15T06:00:15.000Z","date":"2022-12-14","kind":"purchase","acquired":true,"shares":23000,"price":1.2937,"value":29755.1,"ownership":{"direct":true},"balance_after":333118,"source":{"system":"sec-edgar","filing":"0001209191-22-061329","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919122061329/doc4.xml","form_type":"4"}},{"id":2106585,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-22T06:00:15.000Z","date":"2022-11-18","kind":"purchase","acquired":true,"shares":13900,"price":1.41,"value":19599.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.3992 to $1.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":310118,"source":{"system":"sec-edgar","filing":"0001209191-22-058302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919122058302/doc4.xml","form_type":"4"}},{"id":2124225,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-04T06:00:17.000Z","date":"2022-11-03","kind":"purchase","acquired":true,"shares":9200,"price":1.52,"value":13984.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.506 to $1.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":296218,"source":{"system":"sec-edgar","filing":"0001209191-22-055687","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919122055687/doc4.xml","form_type":"4"}},{"id":2125201,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-03T06:00:13.000Z","date":"2022-11-02","kind":"purchase","acquired":true,"shares":6000,"price":1.59,"value":9540.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.5897 to $1.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,500 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on October 20, 2022."}],"balance_after":287018,"source":{"system":"sec-edgar","filing":"0001209191-22-055435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919122055435/doc4.xml","form_type":"4"}},{"id":2139138,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-10-11T06:00:11.000Z","date":"2022-10-07","kind":"purchase","acquired":true,"shares":5000,"price":1.77,"value":8850.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.7601 to $1.7755, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":277518,"source":{"system":"sec-edgar","filing":"0001209191-22-053202","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919122053202/doc4.xml","form_type":"4"}},{"id":2141953,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-10-05T06:00:11.000Z","date":"2022-10-03","kind":"purchase","acquired":true,"shares":5000,"price":1.67,"value":8350.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6650 to $1.6855, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":272518,"source":{"system":"sec-edgar","filing":"0001209191-22-052605","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919122052605/doc4.xml","form_type":"4"}},{"id":2151140,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-09-26T06:00:19.000Z","date":"2022-09-22","kind":"purchase","acquired":true,"shares":5000,"price":1.76,"value":8800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.735 to $1.7899, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":267518,"source":{"system":"sec-edgar","filing":"0001209191-22-051200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919122051200/doc4.xml","form_type":"4"}},{"id":2202605,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-25T06:00:19.000Z","date":"2022-07-22","kind":"purchase","acquired":true,"shares":4500,"price":1.85,"value":8325.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.835 to $1.8499, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":262518,"source":{"system":"sec-edgar","filing":"0001209191-22-043061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919122043061/doc4.xml","form_type":"4"}},{"id":2207423,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-14T06:00:14.000Z","date":"2022-07-13","kind":"purchase","acquired":true,"shares":3000,"price":1.84,"value":5520.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.83 to $1.8426, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":258018,"source":{"system":"sec-edgar","filing":"0001209191-22-042093","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919122042093/doc4.xml","form_type":"4"}},{"id":2207422,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-14T06:00:14.000Z","date":"2022-07-12","kind":"purchase","acquired":true,"shares":3000,"price":1.87,"value":5610.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.86 to $1.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":255018,"source":{"system":"sec-edgar","filing":"0001209191-22-042093","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919122042093/doc4.xml","form_type":"4"}},{"id":2227322,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-06-17T18:00:11.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the number of shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of the grant date, subject to the Reporting Person's continued service through such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.08,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-038030","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260990/000120919122038030/doc4.xml","form_type":"4"}},{"id":2256410,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-25T23:06:48.000Z","date":"2022-05-23","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatically granted pursuant to the terms of the Company's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 23, 2023 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 23, 2025. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan)."}],"balance_after":22500,"derivative":{"exercise_price":7.77,"expiration_date":"2032-05-22","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001567619-22-011722","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631338/000156761922011722/doc1.xml","form_type":"4"}},{"id":2274562,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-05-11T06:00:17.000Z","date":"2022-05-09","kind":"purchase","acquired":true,"shares":10000,"price":1.85,"value":18500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.80 to $1.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":252018,"source":{"system":"sec-edgar","filing":"0001209191-22-028188","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919122028188/doc4.xml","form_type":"4"}},{"id":2275939,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-05-10T06:00:14.000Z","date":"2022-05-06","kind":"purchase","acquired":true,"shares":2500,"price":1.97,"value":4925.0,"ownership":{"direct":true},"balance_after":242018,"source":{"system":"sec-edgar","filing":"0001209191-22-027975","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919122027975/doc4.xml","form_type":"4"}},{"id":2283839,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-05-03T06:00:11.000Z","date":"2022-04-29","kind":"purchase","acquired":true,"shares":5000,"price":1.9709,"value":9854.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.9717 to $1.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":239518,"source":{"system":"sec-edgar","filing":"0001209191-22-026562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919122026562/doc4.xml","form_type":"4"}},{"id":2290998,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-25T06:00:10.000Z","date":"2022-04-21","kind":"purchase","acquired":true,"shares":4500,"price":2.3,"value":10350.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,500 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on April 20, 2022."}],"balance_after":234518,"source":{"system":"sec-edgar","filing":"0001209191-22-025471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919122025471/doc4.xml","form_type":"4"}},{"id":2298242,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-12T06:00:11.000Z","date":"2022-04-08","kind":"purchase","acquired":true,"shares":2000,"price":2.5,"value":5000.0,"ownership":{"direct":true},"balance_after":226518,"source":{"system":"sec-edgar","filing":"0001209191-22-024070","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919122024070/doc4.xml","form_type":"4"}},{"id":2310845,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-01T06:05:10.000Z","date":"2022-03-30","kind":"purchase","acquired":true,"shares":4000,"price":2.7,"value":10800.0,"ownership":{"direct":true},"balance_after":224518,"source":{"system":"sec-edgar","filing":"0001209191-22-021876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919122021876/doc4.xml","form_type":"4"}},{"id":2319842,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-23T06:00:10.000Z","date":"2022-03-21","kind":"purchase","acquired":true,"shares":1200,"price":2.45,"value":2940.0,"ownership":{"direct":true},"balance_after":220518,"source":{"system":"sec-edgar","filing":"0001209191-22-020678","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919122020678/doc4.xml","form_type":"4"}},{"id":2418895,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-02-01T17:00:51.000Z","date":"2022-01-28","kind":"grant","acquired":true,"shares":265000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to this option shall vest on the first anniversary of the Grant Date shown in column 3 above.  The remaining shares vest and become exercisable in 36 equal monthly installments thereafter, on the last day of each month."}],"balance_after":265000,"derivative":{"exercise_price":2.32,"expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":265000},"source":{"system":"sec-edgar","filing":"0001209191-22-005939","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919122005939/doc4.xml","form_type":"4"}},{"id":2500203,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-22T16:21:05.000Z","date":"2021-11-19","kind":"purchase","acquired":true,"shares":3500,"price":2.82,"value":9870.0,"ownership":{"direct":true},"balance_after":219318,"source":{"system":"sec-edgar","filing":"0001209191-21-066096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919121066096/doc4.xml","form_type":"4"}},{"id":2500202,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-22T16:21:05.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":681,"price":2.88,"value":1961.28,"ownership":{"direct":true},"balance_after":215818,"source":{"system":"sec-edgar","filing":"0001209191-21-066096","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919121066096/doc4.xml","form_type":"4"}},{"id":2519211,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-09T07:00:11.000Z","date":"2021-11-05","kind":"purchase","acquired":true,"shares":3000,"price":3.415,"value":10245.0,"ownership":{"direct":true},"balance_after":215137,"source":{"system":"sec-edgar","filing":"0001209191-21-063520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919121063520/doc4.xml","form_type":"4"}},{"id":2519210,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-09T07:00:11.000Z","date":"2021-11-05","kind":"purchase","acquired":true,"shares":1000,"price":3.41,"value":3410.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,405 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on October 20, 2021."}],"balance_after":212137,"source":{"system":"sec-edgar","filing":"0001209191-21-063520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919121063520/doc4.xml","form_type":"4"}},{"id":2597424,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-08-18T06:05:08.000Z","date":"2021-08-16","kind":"purchase","acquired":true,"shares":3000,"price":3.56,"value":10680.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3500 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on April 20, 2021."}],"balance_after":207732,"source":{"system":"sec-edgar","filing":"0001209191-21-052132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919121052132/doc4.xml","form_type":"4"}},{"id":2692929,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-05-27T18:06:30.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the number of shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of the grant date, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":5.14,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-036318","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260990/000120919121036318/doc4.xml","form_type":"4"}},{"id":2704808,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-20T00:36:00.000Z","date":"2021-05-17","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatically granted pursuant to the terms of the Company's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan)."}],"balance_after":22500,"derivative":{"exercise_price":26.89,"expiration_date":"2031-05-16","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001567619-21-010751","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631338/000156761921010751/doc1.xml","form_type":"4"}},{"id":2884849,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-02T18:00:26.000Z","date":"2021-01-29","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to this option shall vest on the first anniversary of the Grant Date shown in column 3 above.  The remaining shares vest and become exercisable in 36 equal monthly installments thereafter, on the last day of each month."}],"balance_after":180000,"derivative":{"exercise_price":9.14,"expiration_date":"2031-01-28","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001209191-21-006882","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919121006882/doc4.xml","form_type":"4"}},{"id":2891892,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-28T06:00:15.000Z","date":"2021-01-27","kind":"purchase","acquired":true,"shares":11000,"price":8.9792,"value":98771.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.93 to $9.079, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":201232,"source":{"system":"sec-edgar","filing":"0001209191-21-005826","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919121005826/doc4.xml","form_type":"4"}},{"id":2928554,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-30T06:00:09.000Z","date":"2020-12-29","kind":"purchase","acquired":true,"shares":1000,"price":9.98,"value":9980.0,"ownership":{"direct":true},"balance_after":190232,"source":{"system":"sec-edgar","filing":"0001209191-20-065423","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120065423/doc4.xml","form_type":"4"}},{"id":3000517,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-10-23T06:00:15.000Z","date":"2020-10-21","kind":"purchase","acquired":true,"shares":2000,"price":4.3845,"value":8769.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 350 shares acquired by the reporting person under the Issuer's 2015 Employee Stock Purchase Plan on October 20, 2020."}],"balance_after":189232,"source":{"system":"sec-edgar","filing":"0001209191-20-055634","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120055634/doc4.xml","form_type":"4"}},{"id":3022278,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-09-25T06:00:20.000Z","date":"2020-09-23","kind":"purchase","acquired":true,"shares":107,"price":4.7201,"value":505.0507,"ownership":{"direct":true},"balance_after":186882,"source":{"system":"sec-edgar","filing":"0001209191-20-052046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120052046/doc4.xml","form_type":"4"}},{"id":3022277,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-09-25T06:00:20.000Z","date":"2020-09-23","kind":"purchase","acquired":true,"shares":4893,"price":4.7198,"value":23093.9814,"ownership":{"direct":true},"balance_after":186775,"source":{"system":"sec-edgar","filing":"0001209191-20-052046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120052046/doc4.xml","form_type":"4"}},{"id":3035165,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-09-09T06:00:18.000Z","date":"2020-09-04","kind":"purchase","acquired":true,"shares":5000,"price":2.55,"value":12750.0,"ownership":{"direct":true},"balance_after":181882,"source":{"system":"sec-edgar","filing":"0001209191-20-049800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120049800/doc4.xml","form_type":"4"}},{"id":3035164,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-09-09T06:00:18.000Z","date":"2020-09-04","kind":"purchase","acquired":true,"shares":5000,"price":2.6,"value":13000.0,"ownership":{"direct":true},"balance_after":176882,"source":{"system":"sec-edgar","filing":"0001209191-20-049800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120049800/doc4.xml","form_type":"4"}},{"id":3047422,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-08-25T06:00:16.000Z","date":"2020-08-21","kind":"purchase","acquired":true,"shares":5325,"price":1.56,"value":8307.0,"ownership":{"direct":true},"balance_after":171882,"source":{"system":"sec-edgar","filing":"0001209191-20-048180","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120048180/doc4.xml","form_type":"4"}},{"id":3048446,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-08-24T06:06:15.000Z","date":"2020-08-20","kind":"purchase","acquired":true,"shares":30000,"price":1.58,"value":47400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.57 to $1.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":166557,"source":{"system":"sec-edgar","filing":"0001209191-20-048026","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120048026/doc4.xml","form_type":"4"}},{"id":3053607,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-08-18T20:28:38.000Z","date":"2020-08-18","kind":"purchase","acquired":true,"shares":44743,"price":1.6282,"value":72850.5526,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.59 to $1.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":136557,"source":{"system":"sec-edgar","filing":"0001209191-20-047364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120047364/doc4.xml","form_type":"4"}},{"id":3053606,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-08-18T20:28:38.000Z","date":"2020-08-14","kind":"purchase","acquired":true,"shares":100,"price":1.7015,"value":170.15,"ownership":{"direct":true},"balance_after":91814,"source":{"system":"sec-edgar","filing":"0001209191-20-047364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120047364/doc4.xml","form_type":"4"}},{"id":3057006,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-08-14T20:17:45.000Z","date":"2020-08-13","kind":"purchase","acquired":true,"shares":5000,"price":1.65,"value":8250.0,"ownership":{"direct":true},"balance_after":91714,"source":{"system":"sec-edgar","filing":"0001209191-20-046866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120046866/doc4.xml","form_type":"4"}},{"id":3057005,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-08-14T20:17:45.000Z","date":"2020-08-12","kind":"purchase","acquired":true,"shares":10000,"price":1.79,"value":17900.0,"ownership":{"direct":true},"balance_after":86714,"source":{"system":"sec-edgar","filing":"0001209191-20-046866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120046866/doc4.xml","form_type":"4"}},{"id":3057004,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-08-14T20:17:45.000Z","date":"2020-08-12","kind":"purchase","acquired":true,"shares":5000,"price":1.67,"value":8350.0,"ownership":{"direct":true},"balance_after":76714,"source":{"system":"sec-edgar","filing":"0001209191-20-046866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120046866/doc4.xml","form_type":"4"}},{"id":3072379,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-07-31T21:06:20.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4 reported the acquisition of the Stock Options in the \"D\" column of Column 5.  This amendment is being filed to correctly report the acquisition of the Stock Options in the \"A\" column of Column 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-twelfth of the number of shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of grant date, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":2.94,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-044388","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260990/000120919120044388/doc4a.xml","form_type":"4/A","original_submission_date":"2020-06-12"}},{"id":3072373,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-07-31T21:05:46.000Z","date":"2019-09-12","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4 reported the acquisition of the Stock Options in the \"D\" column of Column 5.  This amendment is being filed to correctly report the acquisition of the Stock Options in the \"A\" column of Column 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One thirty-sixth of each Effective Date Award and each Initial Award shall vest and become exercisable in substantially equal installments on each monthly anniversary of the date of grant, so that the options subject to each such type of award shall be fully vested on the three-year anniversary of the date of grant, subject to the Reporting Persons continued service on the Board through each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":5.76,"expiration_date":"2029-09-12","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-20-044375","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260990/000120919120044375/doc4a.xml","form_type":"4/A","original_submission_date":"2019-09-16"}},{"id":3099584,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-06-25T17:46:01.000Z","date":"2020-06-24","kind":"purchase","acquired":true,"shares":9895,"price":1.9,"value":18800.5,"ownership":{"direct":true},"balance_after":71714,"source":{"system":"sec-edgar","filing":"0001209191-20-038961","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120038961/doc4.xml","form_type":"4"}},{"id":3111601,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-06-12T16:41:43.000Z","date":"2020-06-11","kind":"grant","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of  the number of shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of the grant date, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":2.94,"expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-036307","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260990/000120919120036307/doc4.xml","form_type":"4"}},{"id":3134770,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-26T17:00:14.000Z","date":"2020-05-22","kind":"purchase","acquired":true,"shares":592,"price":1.89,"value":1118.88,"ownership":{"direct":true},"balance_after":61819,"source":{"system":"sec-edgar","filing":"0001209191-20-032058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120032058/doc4.xml","form_type":"4"}},{"id":3134769,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-26T17:00:14.000Z","date":"2020-05-22","kind":"purchase","acquired":true,"shares":10000,"price":1.9,"value":19000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 350 shares acquired by the reporting person under the Issuer's 2015 Employee Stock Purchase Plan on April 20, 2020."}],"balance_after":61227,"source":{"system":"sec-edgar","filing":"0001209191-20-032058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120032058/doc4.xml","form_type":"4"}},{"id":3210480,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-13T18:21:17.000Z","date":"2020-03-13","kind":"purchase","acquired":true,"shares":4100,"price":1.1279,"value":4624.39,"ownership":{"direct":true},"balance_after":50877,"source":{"system":"sec-edgar","filing":"0001209191-20-019015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120019015/doc4.xml","form_type":"4"}},{"id":3213025,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-12T16:32:10.000Z","date":"2020-03-12","kind":"purchase","acquired":true,"shares":5000,"price":1.1716,"value":5858.0,"ownership":{"direct":true},"balance_after":46777,"source":{"system":"sec-edgar","filing":"0001209191-20-018516","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120018516/doc4.xml","form_type":"4"}},{"id":3213024,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-12T16:32:10.000Z","date":"2020-03-12","kind":"purchase","acquired":true,"shares":5000,"price":1.1889,"value":5944.5,"ownership":{"direct":true},"balance_after":41777,"source":{"system":"sec-edgar","filing":"0001209191-20-018516","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120018516/doc4.xml","form_type":"4"}},{"id":3213023,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-12T16:32:10.000Z","date":"2020-03-11","kind":"purchase","acquired":true,"shares":5000,"price":1.6575,"value":8287.5,"ownership":{"direct":true},"balance_after":36777,"source":{"system":"sec-edgar","filing":"0001209191-20-018516","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120018516/doc4.xml","form_type":"4"}},{"id":3213022,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-12T16:32:10.000Z","date":"2020-03-11","kind":"purchase","acquired":true,"shares":5000,"price":1.7098,"value":8549.0,"ownership":{"direct":true},"balance_after":31777,"source":{"system":"sec-edgar","filing":"0001209191-20-018516","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120018516/doc4.xml","form_type":"4"}},{"id":3217246,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-10T18:02:31.000Z","date":"2020-03-10","kind":"purchase","acquired":true,"shares":10000,"price":1.8691,"value":18691.0,"ownership":{"direct":true},"balance_after":26777,"source":{"system":"sec-edgar","filing":"0001209191-20-017824","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120017824/doc4.xml","form_type":"4"}},{"id":3290740,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-02-04T16:10:40.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":123200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to this option shall vest on the first anniversary of the Grant Date shown in column 3 above.  The remaining shares vest and become exercisable in 36 equal monthly installments thereafter, on the last day of each month."}],"balance_after":123200,"derivative":{"exercise_price":4.02,"expiration_date":"2030-01-30","underlying":"Common Stock","underlying_shares":123200},"source":{"system":"sec-edgar","filing":"0001209191-20-006280","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120006280/doc4.xml","form_type":"4"}},{"id":3302539,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-01-24T16:08:59.000Z","date":"2020-01-22","kind":"tax_withholding","acquired":false,"shares":929,"price":3.76,"value":3493.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On October 18, 2019, the reporting person acquired 3,500 shares under the Issuer's 2015 Employee Stock Purchase Plan. On November 7, 2019, the Issuer effected a 10 for 1 reverse split of its common stock, upon which the reporting person's ownership was reduced by 159,359 shares of common stock."}],"balance_after":16777,"source":{"system":"sec-edgar","filing":"0001209191-20-004805","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919120004805/doc4.xml","form_type":"4"}},{"id":3413741,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-09-16T17:44:11.000Z","date":"2019-09-12","kind":"grant","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One thirty-sixth of each Effective Date Award and each Initial Award shall vest and become exercisable in substantially equal installments on each monthly anniversary of the date of grant, so that the options subject to each such type of award shall be fully vested on the three-year anniversary of the date of grant, subject to the Reporting Persons continued service on the Board through each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":5.76,"expiration_date":"2029-09-12","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-049697","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260990/000120919119049697/doc4.xml","form_type":"4"}},{"id":3440781,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-12T11:40:26.000Z","date":"2019-08-09","kind":"purchase","acquired":true,"shares":50000,"price":0.45,"value":22500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.445695\nto $0.447, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities\nand Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set\nforth above"}],"balance_after":173565,"source":{"system":"sec-edgar","filing":"0001209191-19-045450","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919119045450/doc4.xml","form_type":"4"}},{"id":3493919,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-11T18:34:07.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":14677,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 11,007 shares of restricted stock subject to continuing time-based vesting."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger dated as of April 30, 2019 (the \"Merger Agreement\"), by and among Oncternal Therapeutics, Inc. (\"Old Oncternal\"), GTx, Inc. (\"GTx\") and certain of their subsidiaries, on June 7, 2019 (the \"Effective Time\"), GTx was merged with and into Old Oncternal, with GTx surviving as the continuing entity. At the Effective Time, each share of Old Oncternal common stock issued and outstanding immediately prior to such time was converted into the right to receive 0.073386 shares of the Issuer's common stock. On the trading day immediately prior to the effective time, the closing price of the Issuer's common stock was $1.20 per share."}],"balance_after":14677,"source":{"system":"sec-edgar","filing":"0000899243-19-016478","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260990/000089924319016478/doc4.xml","form_type":"4"}},{"id":3689129,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-01-23T16:48:45.000Z","date":"2019-01-22","kind":"tax_withholding","acquired":false,"shares":9290,"price":1.0401,"value":9662.529,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of restricted stock units."}],"balance_after":123565,"source":{"system":"sec-edgar","filing":"0001209191-19-004987","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919119004987/doc4.xml","form_type":"4"}},{"id":3720692,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-12-21T18:32:40.000Z","date":"2018-12-21","kind":"purchase","acquired":true,"shares":49000,"price":0.6576,"value":32222.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6286\nto $0.6769, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities\nand Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set\nforth above"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,500 shares acquired on April 20, 2018 and 3,500 shares acquired on October 19, 2018, pursuant to the Issuer's 2015 Equity Incentive Plan."}],"balance_after":132855,"source":{"system":"sec-edgar","filing":"0001209191-18-063993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919118063993/doc4.xml","form_type":"4"}},{"id":4036513,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-02-23T19:01:19.000Z","date":"2018-02-21","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to this option shall vest on the first anniversary of the Grant Date shown in column 3 above.  The remaining shares vest and become exercisable in 36 equal monthly installments thereafter, on the last day of each month."}],"balance_after":225000,"derivative":{"exercise_price":2.15,"expiration_date":"2028-02-20","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-18-013143","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919118013143/doc4.xml","form_type":"4"}},{"id":4092179,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-01-23T19:11:50.000Z","date":"2018-01-22","kind":"tax_withholding","acquired":false,"shares":9290,"price":2.95,"value":27405.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of restricted stock units."}],"balance_after":76855,"source":{"system":"sec-edgar","filing":"0001209191-18-004999","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919118004999/doc4.xml","form_type":"4"}},{"id":4482784,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-01-24T19:27:17.000Z","date":"2017-01-20","kind":"grant","acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to this option shall vest on the first anniversary of the Grant Date shown in column 3 above.  The remaining shares vest and become exercisable in 36 equal monthly installments thereafter, on the last day of each month."}],"balance_after":190000,"derivative":{"exercise_price":5.15,"expiration_date":"2027-01-19","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001209191-17-005418","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919117005418/doc4.xml","form_type":"4"}},{"id":4482783,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":36685,"kind":"person","name":"THEUER CHARLES","position":1,"cik":"0001631338","reported_name":"THEUER CHARLES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-01-24T19:27:17.000Z","date":"2016-01-23","kind":"tax_withholding","acquired":false,"shares":9870,"price":4.85,"value":47869.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,615 shares acquired under the 2015 Employee Stock Purchase Plan on April 20, 2016."}],"balance_after":86145,"source":{"system":"sec-edgar","filing":"0001209191-17-005418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394319/000120919117005418/doc4.xml","form_type":"4"}}]}